The immune system may hold a biological key to distinguishing psychiatric conditions that clinicians currently separate largely by symptom checklists. If specific inflammatory receptor profiles in a routine blood draw can differentiate schizophrenia spectrum disorders from mood disorders, it would represent a meaningful step toward objective biomarker-assisted diagnosis in psychiatry — a field long starved of such tools.
This systematic review and meta-analysis, registered in PROSPERO and drawing on five major databases, synthesized data from 26 studies comprising roughly 1,400 psychiatric patients and 1,182 healthy controls. Peripheral blood mRNA levels of toll-like receptors (TLRs) — pattern-recognition molecules that trigger innate immune responses — were quantified across TLR1 through TLR10. In schizophrenia spectrum disorders, TLR4, TLR8, and TLR10 were significantly upregulated (Hedges' g ranging 0.26–0.31, FDR-corrected p < 0.05). Mood disorders instead showed elevations in TLR2, TLR5, and TLR6 (g = 0.23–0.32). These non-overlapping signatures imply that each condition activates innate immunity through mechanistically distinct ligand-recognition pathways — one favoring broad microbial threat detection, the other skewing toward bacterial pattern recognition.
This finding matters beyond diagnostic taxonomy. TLR4 in schizophrenia is particularly noteworthy: it is the canonical receptor for lipopolysaccharide, a gram-negative bacterial endotoxin, but also responds to endogenous damage signals, linking it to neuroinflammatory cascades already implicated in psychosis models. TLR2 and TLR6 elevation in mood disorders aligns with emerging literature on gut-derived bacterial translocation and its effects on depression-related neuroimmune signaling. The effect sizes are modest and the total sample relatively small, limiting immediate clinical translation. Importantly, the studies are largely cross-sectional and cannot establish whether TLR dysregulation is causal, consequential, or a treatment artifact. Nonetheless, the disorder-specificity of the signatures — confirmed across multiple receptors and replicated across independent cohorts in meta-analytic form — elevates this beyond incremental noise. It represents a genuinely hypothesis-generating finding for immune-stratified psychiatric research.